Kau patent opposition analysis

The comprehensive analysis of Kau opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Kau

Patent NumberTitleApplicantOpposition DateOpposition Company
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKApr 19, 2026TEVA PHARMACEUTICALS
Starting Dose Of Pth ConjugatesASCENDIS PHARMA BONE DISEASESApr 1, 2026TEVA PHARMACEUTICALS
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMar 10, 2026TEVA PHARMACEUTICALS
Methods Of Treating Prostate CancerJANSSEN PHARMACEUTICAOct 21, 2025TEVA PHARMACEUTICALS
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSJul 16, 2025TEVA PHARMACEUTICALS
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMay 7, 2025TEVA PHARMACEUTICALS
Compounds And Methods For Treatment Of Inflammatory Bowel Disease With Extra-Intestinal ManifestationsARENA PHARMACEUTICALSFeb 1, 2025TEVA PHARMACEUTICALS
Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein ReductionTHE MEDICINESJan 17, 2025TEVA PHARMACEUTICALS
Polymorphic Forms Of Rad1901-2HclRADIUS PHARMACEUTICALSJan 10, 2025TEVA PHARMACEUTICALS
Feed Screw-Type Machine For Feeding A Processing Screw-Type Machine, And Related MethodCOPERIONJan 2, 2025KRAUSSMAFFEI EXTRUSION